1. Home
  2. Clinical Topics
  3. Women's Health
  4. Aging
  5. FDA issues proposed guidelines for developing drugs for Alzheimer’s disease
AgingClinical TopicsDrugs and DevicesNeurologyNewsWeb Exclusives

FDA issues proposed guidelines for developing drugs for Alzheimer’s disease

Share

On Feb. 7, 2013, the U.S. Food and Drug Administration (FDA) issued a proposal designed to help companies developing new treatments for patients in the early stages of Alzheimer’s disease. Read more.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts